THE INVISIBLE BURDEN OF ENDOMETRIOSIS: A REVIEW OF DIAGNOSTIC, TREATMENT, AND HEALTH POLICY CHALLENGES

In: International Journal of Innovative Technologies in Social Science · 2026 · vol. 2(2(50)) · doi:10.31435/ijitss.2(50).2026.5494 · W7163524332
article OA: gold CC0
AI-generated summary by claude@2026-06, 2026-06-07

This review examines the epidemiology, quality of life impact, diagnostic delays, treatment limitations, and health policy challenges associated with endometriosis, a prevalent chronic inflammatory disease.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

AI-generated deep summary by claude@2026-06, 2026-06-07 · read from full text

This narrative review synthesizes literature from major databases to characterize the multifaceted burden of endometriosis, focusing on epidemiology, quality-of-life and productivity impacts, diagnostic delays, treatment limitations, and health policy barriers. Across included studies and policy reports, the review finds that endometriosis contributes substantial physical, psychological, and economic costs, with ongoing delays driven by patient, provider, and system-level factors, while current treatments have limited effectiveness/accessibility and high recurrence rates. A key limitation is that, as a narrative review, it synthesizes evidence without a fully systematic approach to study selection and weighting. This paper is centrally about endometriosis — it reviews diagnostic, treatment, and health-policy challenges that drive the overall burden of the disease.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Background: Endometriosis is a chronic, estrogen-dependent inflammatory disease affecting approximately 6-13% of women worldwide, with estimates exceeding 100 million individuals. It presents with heterogeneous symptoms, including chronic pelvic pain, dysmenorrhea, dyspareunia, and infertility, significantly impairing quality of life. Despite its prevalence, endometriosis remains under-recognized and often inadequately addressed at clinical and policy levels. Objective: This review aims to examine the multifaceted burden of endometriosis, including its epidemiology, impact on quality of life and productivity, diagnostic delays, treatment limitations, and health system and policy barriers. Methods: A narrative review of the literature was conducted using major databases, including PubMed, Scopus, and Web of Science. Recent systematic reviews, meta-analyses, observational studies, and policy reports were analyzed to identify key themes and evidence gaps. Results: Endometriosis is associated with substantial physical, psychological, and economic burden, including reduced work productivity and high healthcare costs. Diagnostic delay remains a major challenge due to factors at the patient, provider, and system levels. Current treatments are often limited in effectiveness and accessibility, with high recurrence rates. Fragmented healthcare systems, insufficient specialist training, and a lack of national policies further exacerbate inequalities in care. Conclusions: Endometriosis represents a significant yet often invisible public health issue. Addressing its burden requires integrated care models, improved diagnostic strategies, increased research funding, and comprehensive policy action.
Full text 9,280 characters · extracted from oa-doi-fallback · 6 sections · click to expand

Background

Endometriosis is a chronic, estrogen-dependent inflammatory disease affecting approximately 6-13% of women worldwide, with estimates exceeding 100 million individuals. It presents with heterogeneous symptoms, including chronic pelvic pain, dysmenorrhea, dyspareunia, and infertility, significantly impairing quality of life. Despite its prevalence, endometriosis remains under-recognized and often inadequately addressed at clinical and policy levels.

Objective

This review aims to examine the multifaceted burden of endometriosis, including its epidemiology, impact on quality of life and productivity, diagnostic delays, treatment limitations, and health system and policy barriers.

Methods

A narrative review of the literature was conducted using major databases, including PubMed, Scopus, and Web of Science. Recent systematic reviews, meta-analyses, observational studies, and policy reports were analyzed to identify key themes and evidence gaps.

Results

Endometriosis is associated with substantial physical, psychological, and economic burden, including reduced work productivity and high healthcare costs. Diagnostic delay remains a major challenge due to factors at the patient, provider, and system levels. Current treatments are often limited in effectiveness and accessibility, with high recurrence rates. Fragmented healthcare systems, insufficient specialist training, and a lack of national policies further exacerbate inequalities in care.

Conclusions

Endometriosis represents a significant yet often invisible public health issue. Addressing its burden requires integrated care models, improved diagnostic strategies, increased research funding, and comprehensive policy action.

References

Adamson, G. D., Kennedy, S., & Hummelshoj, L. (2010). Creating solutions in endometriosis: Global collaboration through the World Endometriosis Research Foundation. Journal of Endometriosis, 2(1), 3–6. https://doi.org/10.1177/228402651000200102 As-Sanie, S., Mackenzie, S. C., Morrison, L., Schrepf, A., Zondervan, K. T., Horne, A. W., & Missmer, S. A. (2025). Endometriosis: A review. JAMA, 334(1), 64. https://doi.org/10.1001/jama.2025.2975 Ballweg, M. L. (2004). Impact of endometriosis on women’s health: Comparative historical data show that the earlier the onset, the more severe the disease. Best Practice & Research Clinical Obstetrics & Gynaecology, 18(2), 201–218. https://doi.org/10.1016/j.bpobgyn.2004.01.003 Ellis, K., Munro, D., & Wood, R. (2022). The experiences of endometriosis patients with diagnosis and treatment in New Zealand. Frontiers in Global Women’s Health, 3, Article 991045. https://doi.org/10.3389/fgwh.2022.991045 Ellis, K., Munro, D., & Wood, R. (2023). Dismissal informs the priorities of endometriosis patients in New Zealand. Frontiers in Medicine, 10, Article 1185769. https://doi.org/10.3389/fmed.2023.1185769 Evans, D., Gibbons, T., Skidmore, B., Zondervan, K. T., Adamson, G. D., Giudice, L. C., Missmer, S. A., Abbott, J., Abrao, M., Becker, C., Bush, D., Canis, M., Cox, E., Dyer, S., Farquhar, C., Flores, I., Gajbhiye, R., Guo, S., Gupta, J., … Zhang, J. (2025). Availability of region-specific endometriosis care guidance: A global scoping review. The Lancet Obstetrics, Gynaecology, & Women’s Health, 1(3), e219–e231. https://doi.org/10.1016/j.lanogw.2025.100004 Gibbons, T., Evans, D., Skidmore, B., Becker, C. M., Missmer, S. A., Giudice, L. C., Adamson, G. D., Zondervan, K. T., Abbott, J., Abrao, M., Bush, D., Canis, M., Cox, E., Dyer, S., Farquhar, C., Flores, I., Gajbhiye, R., Guo, S., Gupta, J., … Zhang, J. (2025). Endometriosis policy and delivery systems: A comprehensive global scoping review. The Lancet Obstetrics, Gynaecology, & Women’s Health, 1(3), e232–e244. https://doi.org/10.1016/j.lanogw.2025.100027 Hudson, Q. J., Perricos, A., Wenzl, R., & Yotova, I. (2020). Challenges in uncovering non-invasive biomarkers of endometriosis. Experimental Biology and Medicine, 245(5), 437–447. https://doi.org/10.1177/1535370220903270 Karavadra, B., Thorpe, G., Morris, E., & Semlyen, J. (2025). Exploring delay to diagnosis of endometriosis, a healthcare professional perspective. BMC Health Services Research, 25(1), Article 1483. https://doi.org/10.1186/s12913-025-13536-5 Kirk, U. B., Bank-Mikkelsen, A. S., Rytter, D., Hartwell, D., Marschall, H., Nyegaard, M., Seyer-Hansen, M., & Hansen, K. E. (2024). Understanding endometriosis underfunding and its detrimental impact on awareness and research. NPJ Women’s Health, 2(1), Article 45. https://doi.org/10.1038/s44294-024-00048-6 Martínez-Zamora, M. A., Feixas, G., Palou, E., Flo, E., Mallorquí, A., Gracia, M., Gresle, A.-S., Escarrabill, J., & Carmona, F. (2025). Unmet needs of endometriosis patients with respect to health care services: A qualitative study using a patient training workshop. Journal of Clinical Medicine, 14(10), Article 3504. https://doi.org/10.3390/jcm14103504 Mburu, G., Kiarie, J., & Allotey, P. (2025). Advancing policies, guidelines, and service delivery for endometriosis: Call to action. The Lancet Obstetrics, Gynaecology, & Women’s Health, 1(3), e153–e155. https://doi.org/10.1016/j.lanogw.2025.09.010 Mick, I., Freger, S. M., Van Keizerswaard, J., Gholiof, M., & Leonardi, M. (2024). Comprehensive endometriosis care: A modern multimodal approach for the treatment of pelvic pain and endometriosis. Therapeutic Advances in Reproductive Health, 18, Article 26334941241277759. https://doi.org/10.1177/26334941241277759 Moradi, Y., Shams-Beyranvand, M., Khateri, S., Gharahjeh, S., Tehrani, S., Varse, F., Tiyuri, A., & Najmi, Z. (2021). A systematic review on the prevalence of endometriosis in women. Indian Journal of Medical Research, 154(3), 446–454. https://doi.org/10.4103/ijmr.IJMR_817_18 Nnoaham, K. E., Hummelshoj, L., Webster, P., d’Hooghe, T., De Cicco Nardone, F., De Cicco Nardone, C., Jenkinson, C., Kennedy, S. H., & Zondervan, K. T. (2011). Impact of endometriosis on quality of life and work productivity: A multicenter study across ten countries. Fertility and Sterility, 96(2), 366–373.e8. https://doi.org/10.1016/j.fertnstert.2011.05.090 Rahmioglu, N., & Zondervan, K. (2024). Endometriosis: Disease mechanisms and health disparities. Bulletin of the World Health Organization, 102(12), 919–921. https://doi.org/10.2471/BLT.24.292660 Rogers, P. A. W., D’Hooghe, T. M., Fazleabas, A., Gargett, C. E., Giudice, L. C., Montgomery, G. W., Rombauts, L., Salamonsen, L. A., & Zondervan, K. T. (2009). Priorities for endometriosis research: Recommendations from an international consensus workshop. Reproductive Sciences, 16(4), 335–346. https://doi.org/10.1177/1933719108330568 Sarria-Santamera, A., Orazumbekova, B., Terzic, M., Issanov, A., Chaowen, C., & Asúnsolo-del-Barco, A. (2020). Systematic review and meta-analysis of incidence and prevalence of endometriosis. Healthcare, 9(1), Article 29. https://doi.org/10.3390/healthcare9010029 Soliman, A. M., Surrey, E., Bonafede, M., Nelson, J. K., & Castelli-Haley, J. (2018). Real-world evaluation of direct and indirect economic burden among endometriosis patients in the United States. Advances in Therapy, 35(3), 408–423. https://doi.org/10.1007/s12325-018-0667-3 Soliman, A. M., Yang, H., Du, E. X., Kelley, C., & Winkel, C. (2016). The direct and indirect costs associated with endometriosis: A systematic literature review. Human Reproduction, 31(4), 712–722. https://doi.org/10.1093/humrep/dev335 Szymańska, J., & Dąbrowska-Galas, M. (2021). An assessment of Polish women’s level of knowledge about endometriosis: A pilot study. BMC Women’s Health, 21(1), Article 404. https://doi.org/10.1186/s12905-021-01556-2 Szypłowska, M., Tarkowski, R., & Kułak, K. (2023). The impact of endometriosis on depressive and anxiety symptoms and quality of life: A systematic review. Frontiers in Public Health, 11, Article 1230303. https://doi.org/10.3389/fpubh.2023.1230303 Wang, M.-H., Chen, J.-H., Qi, X.-Y., Li, Z.-X., & Huang, Y. (2025). Global prevalence of adenomyosis and endometriosis: A systematic review and meta-analysis. Reproductive Biology and Endocrinology, 23(1), Article 148. https://doi.org/10.1186/s12958-025-01483-z World Health Organization. (2025). Endometriosis. https://www.who.int/news-room/fact-sheets/detail/endometriosis Downloads Published Issue Section License Copyright (c) 2026 Bartosz Janik, Kornelia Domagała, Małgorzata Ziółek, Magdalena Maroszek, Kamil Szymczak, Ariadna Bakier, Albert Wiatr, Agata Olecka, Filip Gałązka, Jakub Cegielski, Nikodem Mozgała, Jakub Ślęzak This work is licensed under a Creative Commons Attribution 4.0 International License. All articles are published in open-access and licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0). Hence, authors retain copyright to the content of the articles. CC BY 4.0 License allows content to be copied, adapted, displayed, distributed, re-published or otherwise re-used for any purpose including for adaptation and commercial use provided the content is attributed.

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosischronic_pelvic_paindysmenorrheadyspareuniainfertility

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (23)

Source provenance

openalex
last seen: 2026-06-06T00:00:02.894732+00:00
License: CC0 · commercial use OK